NCT00084721View on ClinicalTrials.gov

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2005

Conditions
Colorectal CancerDiarrhea
Interventions
DRUG

celecoxib

DRUG

irinotecan hydrochloride

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00084721 - Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter